OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
Roman Maslennikov, Aliya Alieva, Elena Poluektova, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 27, pp. 4236-4251
Open Access | Times Cited: 15

Showing 15 citing articles:

Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies
Youle Zheng, Feng Jin, Yixin Yu, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 4, pp. 301-324
Closed Access | Times Cited: 12

Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study
Irina Efremova, Roman Maslennikov, М. С. Жаркова, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 919-919
Open Access | Times Cited: 8

Correlation between sarcopenia and cirrhosis: a meta-analysis
Yifan Cui, Mingming Zhang, Jing Guo, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 7

Body Composition in Chronic Liver Disease
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 964-964
Open Access | Times Cited: 5

Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis
Ninghui Zhao, Jinjia Bai, Xinmiao Li, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access

Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management
Mazen Elsheikh, Ahmed El Sabagh, Islam Mohamed, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 46, pp. 6028-6048
Open Access | Times Cited: 5

The Application of Rifaximin in Patients with End Stage Liver Disease
皓月 田
Advances in Clinical Medicine (2024) Vol. 14, Iss. 01, pp. 466-475
Closed Access

Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis
Mei‐Tong Nie, Peiqin Wang, Pei‐Mei Shi, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 4, pp. 762-771
Closed Access

Somatotype and microbiome: trends and correlations in liver cirrhosis
Yu. O. Zharikov, A. N. Gadzhiakhmedova, Yana V. Kiseleva, et al.
Science and Innovations in Medicine (2024) Vol. 9, Iss. 3, pp. 164-168
Open Access

Exploring the Relationship Between Gut Microbiota and Sarcopenia Based on Gut–Muscle Axis
Wei Li, Renwang Sheng, Mu‐Min Cao, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 11, pp. 8779-8792
Open Access

Akkermansia muciniphila is associated with normal muscle mass and Eggerthella is related with sarcopenia in cirrhosis
Irina Efremova, Aliya Alieva, Roman Maslennikov, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access

Bioimpedance analysis of body composition and changes in basic metabolism in patients with liver cirrhosis
Yu. O. Zharikov, A. N. Gadzhiakhmedova, Aliya Alieva, et al.
Saratov Journal of Medical Scientific Research (2024) Vol. 20, Iss. 2, pp. 214-218
Open Access

Influence of sarcopenia as determined by bioelectrical impedance analysis in acute pancreatitis
Gizem Seray Kilic, Mustafa Tahtacı, Funda Yagmur, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40868-e40868
Open Access

Page 1

Scroll to top